Indeferimento
#9.2
04/08/2025
RPI 2831
Application data
Number
112019015974Type
Filing
Publication
PCT
US2018016498 The application was refused by the INPI on 04/08/2025. The invention was never patented.
Talk to a specialistLatest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.
Applicants
BEYONDSPRING PHARMACEUTICALS, INC.
US
Inventors
G. L. (pessoa física)
US
L. H. (pessoa física)
US
R. M. (pessoa física)
US
IPC Classification
Priority claims
US
62/453,375 · 02/01/2017
US
62/621,533 · 01/24/2018
Abstract
São divulgados aqui plinabulina e o uso para reduzir neutropenia. Algumas modalidades se referem a reduzir a neutropenia induzida por docetaxel usando plinabulina.
Publications in the Brazilian Industrial Property Gazette (RPI).
#9.2
04/08/2025
RPI 2831
#7.1
12/17/2024
RPI 2815
#7.1
09/03/2024
RPI 2800
#6.23
07/26/2022
RPI 2690
#15.35
10/13/2021
RPI 2649
#1.3
03/31/2020
RPI 2569
#1.1
08/13/2019
RPI 2536
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.